Sumitomo Pharma America Doses First Patient With DSP-3077
MARLBOROUGH, Mass., August 12, 2026 Sumitomo Pharma America, Inc. announced that the first patient has received treatment with DSP-3077...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MARLBOROUGH, Mass., August 12, 2026 Sumitomo Pharma America, Inc. announced that the first patient has received treatment with DSP-3077...
BURLINGTON, Mass., August 12, 2026 Bone Biologics Corporation announced that its rhNELL-1 protein has achieved a validated shelf life...
NEW YORK, July 29, 2026 VB Spine LLC announced that the U.S. Food and Drug Administration (FDA) has granted...
FREDERICK, MARYLAND, April 30, 2026 Theradaptive has received U.S. Food and Drug Administration (FDA) authorization to advance its OASIS...
Seoul, South Korea | April 24, 2025 CGBIO has achieved a major regulatory milestone with the U.S. Food and...
Westminster, Colorado | April 24, 2026 Cerapedics has announced a strategic supplier agreement with Vizient, significantly expanding access to...
CORONADO, CALIFORNIA | January 26, 2026 — Spine Innovation, LLC announced it has received FDA 510(k) clearance to market...
